CGAS and acute kidney injury: Therefore, this study aims to address these gaps by investigating the protective effects of RA-Myr on cisplatin-induced AKI, focusing on its impact on DNA damage and the cGAS-STING pathway, as well as evaluating its long-term stability and biodistribution.